SCHEMBL7328333

SCHEMBL7328333

CCC(=O)C(=O)Nc1ccc(Cl)cc1C(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C19 P33261 1/20 0.59
KDM4E B2RXH2 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
TP53 P04637 2/20 0.54
MAPT P10636 2/20 0.54
ALDH1A1 P00352 4/20 0.52
HTT P42858 2/20 0.52
NPC1 O15118 1/20 0.52
PAX8 Q06710 1/20 0.52
GAA P10253 1/20 0.51
LMNA P02545 3/20 0.48
TRPV1 Q8NER1 1/20 0.47
DHODH Q02127 1/20 0.46
POLB P06746 2/20 0.46
PCTP Q9UKL6 1/20 0.46
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328337 0.82 GPR35 (0.62) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL1503796 0.82 RAB9A (0.66) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL1504061 0.81 RAB9A (0.61) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7573311 0.80 RAB9A (0.68) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL10885626 0.79 RAB9A (0.69) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
Fluoride SCHEMBL10885630 0.77 RAB9A (0.68) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL1091849 0.77 RAB9A (0.68) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL11486413 0.77 HTT (0.61) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL14254814 0.77 ALDH1A1 (0.64) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL12609252 0.77 RAB9A (0.62) RAB9ACYP1A2CYP2D6CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5075304-A Nervous system disorders NOVO NORDISK A/S (DK) 1991-12-24 US disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed
EP-0344943-A1 Imidazoquinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1989-12-06 EP disclosed